Cormorant Asset Management, LP Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$1.3T
Holdings
42
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (42 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 8,494,151 | $400.9B | 29.86% | |
| 2 | EYPTEYEPOINT PHARMACEUTICALS INC | 8,325,000 | $78.3B | 5.84% | |
| 3 | BBIOBRIDGEBIO PHARMA INC | 1,600,000 | $69.1B | 5.15% | |
| 4 | PRAXPRAXIS PRECISION MEDICINES I | 1,625,000 | $68.3B | 5.09% | |
| 5 | MRUSMERUS N V | 1,120,000 | $58.9B | 4.39% | |
| 6 | EWTXEDGEWISE THERAPEUTICS INC | 4,251,992 | $55.7B | 4.15% | |
| 7 | IM8NINSMED INC | 540,000 | $54.3B | 4.05% | |
| 8 | ACLXARCELLX INC | 800,000 | $52.7B | 3.92% | |
| 9 | NAMSNEWAMSTERDAM PHARMA COMPANY | 2,175,000 | $39.4B | 2.93% | |
| 10 | JANXJANUX THERAPEUTICS INC | 1,500,000 | $34.6B | 2.58% | |
| 11 | RAPPRAPPORT THERAPEUTICS INC | 2,940,921 | $33.4B | 2.49% | |
| 12 | VRNAVERONA PHARMA PLC | 350,000 | $33.1B | 2.47% | |
| 13 | HLXCHELIX ACQUISITION CORP II | 2,909,000 | $30.9B | 2.30% | |
| 14 | DRUGBRIGHT MINDS BIOSCIENCES INC | 1,059,331 | $27.7B | 2.06% | |
| 15 | CNTACENTESSA PHARMACEUTICALS PLC | 2,086,600 | $27.4B | 2.04% | |
| 16 | PHVSPHARVARIS N V | 1,454,660 | $25.6B | 1.91% | |
| 17 | GHRSGH RESEARCH PLC | 2,009,482 | $24.5B | 1.82% | |
| 18 | SPRYARS PHARMACEUTICALS INC | 1,100,000 | $19.2B | 1.43% | |
| 19 | CRBPCORBUS PHARMACEUTICALS HLDGS | 2,375,000 | $16.4B | 1.22% | |
| 20 | ABVXABIVAX SA | 2,130,000 | $16.3B | 1.21% | |
| 21 | CGONCG ONCOLOGY INC | 625,000 | $16.3B | 1.21% | |
| 22 | ARQTARCUTIS BIOTHERAPEUTICS INC | 1,000,000 | $14.0B | 1.04% | |
| 23 | CRGXCARGO THERAPEUTICS INC | 3,381,277 | $13.9B | 1.04% | |
| 24 | TARSTARSUS PHARMACEUTICALS INC | 300,000 | $12.2B | 0.91% | |
| 25 | CRNXCRINETICS PHARMACEUTICALS IN | 400,000 | $11.5B | 0.86% | |
| 26 | MTSRMETSERA INC | 400,000 | $11.4B | 0.85% | |
| 27 | AARDAARDVARK THERAPEUTICS INC | 800,189 | $10.8B | 0.81% | |
| 28 | AXSMAXSOME THERAPEUTICS INC | 100,000 | $10.4B | 0.78% | |
| 29 | BIOABIOAGE LABS INC | 2,140,605 | $8.8B | 0.66% | |
| 30 | ENGNENGENE HOLDINGS INC | 2,323,595 | $8.5B | 0.63% | |
| 31 | MBXMBX BIOSCIENCES INC | 700,000 | $8.0B | 0.59% | |
| 32 | CABACABALETTA BIO INC | 5,000,000 | $7.6B | 0.57% | |
| 33 | ALMSALUMIS INC | 2,147,396 | $6.4B | 0.48% | |
| 34 | BMEABIOMEA FUSION INC | 3,570,872 | $6.4B | 0.48% | |
| 35 | KRROKORRO BIO INC | 465,000 | $5.8B | 0.43% | |
| 36 | PCVXVAXCYTE INC | 175,000 | $5.7B | 0.42% | |
| 37 | RNAAVIDITY BIOSCIENCES INC | 200,000 | $5.7B | 0.42% | |
| 38 | ELVNENLIVEN THERAPEUTICS INC | 200,000 | $4.0B | 0.30% | |
| 39 | STOKSTOKE THERAPEUTICS INC | 254,161 | $2.9B | 0.21% | |
| 40 | KALAKALA BIO INC | 603,027 | $2.9B | 0.21% | |
| 41 | VYNEVYNE THERAPEUTICS INC | 1,370,938 | $2.3B | 0.17% | |
| 42 | BHVNBIOHAVEN LTD | 10,000 | $141.1M | 0.01% |